Meet the team
Louise Warme MD, Clinical Innovations Fellow Head of We Venture Capital
Louise is the Head of We Venture Capital, with 10+ years of experience in investments in Life Science and board engagements.
She has a background as a medical doctor and researcher, and is founding CEO of a medtech startup. Louise also holds a Clinical Innovations Fellowship at Karolinska Institute & Royal Institute of Technology, Stockholm, Sweden.
In addition, Louise serves as a director on the board of Axithra and Capitainer and an observer to the board of Deepull and Zetta, our portfolio companies.
Anthony Vallance-Owen MBA, ACA Senior Investment Manager
Anthony is a Senior Investment Manager at We Venture Capital, with 17+ years of experience in business and transactional advice, including M&A, debt, and IPOs.
Anthony was with PWC for 15 years, gaining global experience in the UK, North America, and Asia. He qualified as an ACA chartered accountant and completed his MBA at ESADE, Barcelona, Spain.
In addition, Anthony serves as a director on the board of Zetta and an observer to the board of Capitainer, our portfolio companies.
Gemma Sturt BSc Senior Investment Manager
Gemma is a Senior Investment Manager at We Venture Capital, with a background of 5+ years building and investing in start-ups across life sciences.
She has supported the deployment of several early stage VC funds including at BioCity, which was acquired in 2021, and has worked with various portfolio companies at Board level.
Prior to her investment career, Gemma held commercial roles at two VC-backed start-ups after graduating in Analytical Chemistry from the University of Manchester, United Kingdom, and Università degli Studi di Firenze, Italy.
Gokce Gun MD, MBA Investment Analyst
Gokce is an Investment Analyst at We Venture Capital. She has a background with 8+ years of experience in various roles within the pharmaceutical industry and clinical experience, as well as an MBA from ESADE.
Gokce has served as an emergency physician in the Turkish Ministry of Health and as a Senior Medical Manager in Novartis Oncology.
As an investment analyst, Gokce sources and analyzes investment opportunities for We Venture Capital.
